Hypertriglyceridemia
From Anvita Health Wiki
Contents |
More Specific Terms
Introduction
- Elevated triglycerides in serum.
Etiology
- hyperlipoproteinemias I, IIb, IV, V
- diseases/disorders
- extremely high triglyceride concentrations are common in acute pancreatitis
- non- fasting state
Pathology
- associated with low levels of HDL cholesterol & high levels of small, dense LDL particles
Complications
- uncertain independent association with: [2,3,4]
Management
- non pharmacologic therapy [8]
- aerobic exercise
- weight reduction
- avoid excess alcohol
- fish oil may reduce serum triglycerides via effect on VLDL production
- pharmacologic therapy (serum triglyceride > 500 mg/dL) [10]
-
- not much benefit of fibrate with serum triglyceride < 500 mg/dL (see Field study)
- fenofibrate lowers serum triglycerides, but does not favorably affect adverse cardiovascular events [6] (see ACCORD study)
- fenofibrate may unfavorably affect GFR [6]
- of no outcome benefit when added to statin [9]
- control of associated disorders [8]
- glycemic control in patients with diabetes mellitus
- use of statins in patients with elevated LDL
More General Terms
Additional Terms
- diabetes mellitus
- Field study
- glycogen storage disease (glycogenosis)
- hyperlipoproteinemia (HLP)
- hypothyroidism
- nephrotic syndrome
- pancreatitis
- triglyceride in serum
References
- UpToDate 13.3 [1]
- Avins AL et al Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med 2000 160:1937
- Garber AM & Avins AL, Triglyceride concentration in coronary heart disease. Not yet proved of value as a screening test. BMJ 1994; 309:2
- Cullen P Evidence that triglycerides are an independent coronary heart disease risk factor Am J Cardiol 2000; 86:943
- Simpson HCR et al Hypertriglyceridaemia and hypercoagulability Lancet 1983; 1:786
- The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29;362(17):1563-74 <PubMed> PMID: [2] <Internet> [3]
- Miller M et al Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association Circulation. 2011 Apr 18 <PubMed> PMID: [4] <Internet> [5]
- Prescriber's Letter 18(6): 2011 Strategies for Lowering Triglycerides Detail-Document#: [6] (subscription needed) [7]
- NIH News: Thursday, May 26, 2011 NIH stops clinical trial on combination cholesterol treatment Lack of efficacy in reducing cardiovascular events prompts decision [8]
- Miller M et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2011 May 24 ; 123:2292 PMID: [9]
